<VariationArchive VariationID="861578" VariationName="NM_001723.7(DST):c.3644_3648del (p.Glu1215fs)" VariationType="Deletion" Accession="VCV000861578" Version="8" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2020-04-15" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="832123" VariationID="861578">
      <GeneList>
        <Gene Symbol="DST" FullName="dystonin" GeneID="667" HGNC_ID="HGNC:1090" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="56457996" stop="56954830" display_start="56457996" display_stop="56954830" Strand="-" />
          </Location>
          <OMIM>113810</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001723.7(DST):c.3644_3648del (p.Glu1215fs)</Name>
      <CanonicalSPDI>NC_000006.12:56620385:CCGCTCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="56620386" stop="56620390" display_start="56620386" display_stop="56620390" variantLength="5" positionVCF="56620385" referenceAlleleVCF="CCCGCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="56485184" stop="56485188" display_start="56485184" display_stop="56485188" variantLength="5" positionVCF="56485183" referenceAlleleVCF="CCCGCT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>E1215fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.56485186_56485190del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.56485186_56485190del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.56620388_56620392del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.56620388_56620392del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029322.2" sequenceAccession="NG_029322" sequenceVersion="2" change="g.339239_339243del">
            <Expression>NG_029322.2:g.339239_339243del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001723.7" sequenceAccession="NM_001723" sequenceVersion="7" change="c.3644_3648del" MANEPlusClinical="true">
            <Expression>NM_001723.7:c.3644_3648del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001714.1" sequenceAccession="NP_001714" sequenceVersion="1" change="p.Glu1215fs">
            <Expression>NP_001714.1:p.Glu1215fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001144769.5" sequenceAccession="NM_001144769" sequenceVersion="5" change="c.4830+4140_4830+4144del">
            <Expression>NM_001144769.5:c.4830+4140_4830+4144del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374722.1" sequenceAccession="NM_001374722" sequenceVersion="1" change="c.4929+4140_4929+4144del">
            <Expression>NM_001374722.1:c.4929+4140_4929+4144del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374736.1" sequenceAccession="NM_001374736" sequenceVersion="1" change="c.4929+4140_4929+4144del" MANESelect="true">
            <Expression>NM_001374736.1:c.4929+4140_4929+4144del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374734.1" sequenceAccession="NM_001374734" sequenceVersion="1" change="c.4956+4140_4956+4144del">
            <Expression>NM_001374734.1:c.4956+4140_4956+4144del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001144770.2" sequenceAccession="NM_001144770" sequenceVersion="2" change="c.4416+4140_4416+4144del">
            <Expression>NM_001144770.2:c.4416+4140_4416+4144del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374730.1" sequenceAccession="NM_001374730" sequenceVersion="1" change="c.4296+4140_4296+4144del">
            <Expression>NM_001374730.1:c.4296+4140_4296+4144del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386100.1" sequenceAccession="NM_001386100" sequenceVersion="1" change="c.4296+4140_4296+4144del">
            <Expression>NM_001386100.1:c.4296+4140_4296+4144del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_183380.4" sequenceAccession="NM_183380" sequenceVersion="4" change="c.4296+4140_4296+4144del">
            <Expression>NM_183380.4:c.4296+4140_4296+4144del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374729.1" sequenceAccession="NM_001374729" sequenceVersion="1" change="c.4296+4140_4296+4144del">
            <Expression>NM_001374729.1:c.4296+4140_4296+4144del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015548.5" sequenceAccession="NM_015548" sequenceVersion="5" change="c.3318+4140_3318+4144del">
            <Expression>NM_015548.5:c.3318+4140_3318+4144del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2098678320" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001723.7(DST):c.3644_3648del (p.Glu1215fs) AND multiple conditions" Accession="RCV001068137" Version="7">
        <ClassifiedConditionList TraitSetID="19483">
          <ClassifiedCondition DB="MedGen" ID="C3809470">Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3539003">Hereditary sensory and autonomic neuropathy type 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-12-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-12-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">25059916</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="19483" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18300" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa simplex, autosomal recessive 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa simplex due to BP230 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency</ElementValue>
                <XRef ID="MONDO:0014180" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EBS3</ElementValue>
                <XRef Type="MIM" ID="615425" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.</Attribute>
                <XRef ID="NBK1369" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17690" />
                <XRef ID="17690" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301543</ID>
                <ID Source="BookShelf">NBK1369</ID>
              </Citation>
              <XRef ID="412181" DB="Orphanet" />
              <XRef ID="C3809470" DB="MedGen" />
              <XRef ID="MONDO:0014180" DB="MONDO" />
              <XRef Type="MIM" ID="615425" DB="OMIM" />
            </Trait>
            <Trait ID="17002" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HSAN VI</ElementValue>
                <XRef Type="MIM" ID="614653" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neuropathy, hereditary sensory and autonomic, type VI</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary sensory and autonomic neuropathy type 6</ElementValue>
                <XRef ID="MONDO:0013839" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSAN6</ElementValue>
                <XRef Type="MIM" ID="614653" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12987" />
                <XRef ID="12987" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="314381" DB="Orphanet" />
              <XRef ID="C3539003" DB="MedGen" />
              <XRef ID="MONDO:0013839" DB="MONDO" />
              <XRef Type="MIM" ID="614653" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2398855" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="8935138|MedGen:C3809470;C3539003" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001233227" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-12-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25059916</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in DST are known to be pathogenic (PMID: 25059916). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with DST-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Glu1215Glyfs*11) in the DST gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DST" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.56485184_56485188del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3809470" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3539003" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2398855" TraitType="Disease" MappingType="XRef" MappingValue="C3809470" MappingRef="MedGen">
        <MedGen CUI="C3809470" Name="Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2398855" TraitType="Disease" MappingType="XRef" MappingValue="C3539003" MappingRef="MedGen">
        <MedGen CUI="C3539003" Name="Hereditary sensory and autonomic neuropathy type 6" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

